Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Destiny Pharma's XF-73 Being Studied For Diabetic Foot Ulcers, Burns Too
Sep 27 2018
•
By
Sten Stovall
Destiny Pharma Will Trial XF-73 In Diabetic Foot Ulcers And Burn Wounds • Source: Shutterstock
More from Strategy
More from Business